Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Pakistan set for new regulatory system:

This article was originally published in Clinica

Executive Summary

Pakistan is in the process of approving a new, autonomous agency that will regulate medical devices, to be named the Drug Regulatory Authority. Prime Minister Shaukat Aziz approved the establishment of the DRA at a meeting of senior health officials this month. Designed to streamline the registration of medical products, its responsibilities would include: the enforcement of regulatory laws; accessibility to safe and effective medicines and devices; and rationalisation of pricing. The draft Drug Regulatory Authority Act has been finalised in consultation with stakeholders. Registration documents required for establishing the new authority are yet to be presented to the cabinet for approval.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT053293

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel